PHF19 and colorectal carcinoma: Using the clinical data of TMAs’ patients from Zhongshan cohort, we found that the expression of PHF19 protein (P = 0.025), and AJCC TNM stage (P < 0.001) were considered to be independent risk factors for the prognosis of CRC patients (Table 4).